Arthritis clinical trials

Explore recruiting arthritis clinical trials.

Recruiting arthritis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Arthritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immune-Related Rheumatological and neurological Adverse Events study (IRRAE study)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Filling bone erosions: a longitudinal multicentric HR-pQCT study of subcutaneous tocilizumab in rheumatoid arthritis

France

Therapeutic use (Phase IV) EU CTIS Study details

A3921145 - A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)

Spain, Belgium, Poland

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)

France, Portugal, Belgium, Lithuania, Germany, Netherlands +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Biomarker-guided treatment-and-stop-strategy for recombinant IL-1receptor antagonist (anakinra) in patients with systemic Juvenile Idiopathic Arthritis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA)

Italy, Netherlands, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Arthritis trials by city

Arthritis in Toronto Arthritis in Vancouver Arthritis in Montreal Arthritis in Calgary Arthritis in Edmonton Arthritis in Ottawa Arthritis in Winnipeg Arthritis in Quebec City Arthritis in Hamilton Arthritis in Kitchener Arthritis in London Arthritis in Halifax Arthritis in New York Arthritis in Los Angeles Arthritis in Chicago Arthritis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease